Centro de Atencion e Investigacion Medica

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
Bioequivalence Study of Revolade® Eltrombopag 50 mg	Healthy; Healthy Donors	Active, not recruiting	Phase 4	2025-06-19	NCT06834451
Bioequivalence Study of Clonazepam 2 Mg Tablets	Healthy; Healthy Donors	Not yet recruiting	Phase 4	2025-03-10	NCT06834503
Bioequivalence Study of Lithium Carbonate 300 mg Tablets. Actilitio® in Healthy Subjects	Healthy; Healthy Donors	Active, not recruiting	Phase 4	2025-03-06	NCT06861842
Bioequivalence Study of Pentoxifylline 400 Mg in Healthy Subjects Under Fasting and Fed Conditions	Healthy; Healthy Donors	Not yet recruiting	Phase 4	2025-02-17	NCT06823362
Bioequivalence Studies of Dasatinib 100 Mg	Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell myeloma, plasma cell neoplasm, vascular disorder, vascular hemostatic disease	Not yet recruiting	Phase 4	2025-02-12	NCT05944783

Clinical trials